830 related articles for article (PubMed ID: 34062137)
1. Africa's need for more COVID-19 clinical trials.
Makoni M
Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137
[No Abstract] [Full Text] [Related]
2. HIV and covid-19 in South Africa.
Freer J; Mudaly V
BMJ; 2022 Jan; 376():e069807. PubMed ID: 35086921
[No Abstract] [Full Text] [Related]
3. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Behr MA; Divangahi M; Schurr E
J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccine trials must include helminth-infected cohorts.
Egwang TG; Owalla TJ; Kemigisha M
Nat Immunol; 2022 Feb; 23(2):148. PubMed ID: 35075281
[No Abstract] [Full Text] [Related]
5. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
Rid A; Lipsitch M; Miller FG
JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
[No Abstract] [Full Text] [Related]
6. COVID-19 Vaccine: Practical Clinical Considerations.
Laine C; Cotton D; Moyer DV
Ann Intern Med; 2021 May; 174(5):694. PubMed ID: 33769829
[TBL] [Abstract][Full Text] [Related]
7. How COVID unlocked the power of RNA vaccines.
Dolgin E
Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
[No Abstract] [Full Text] [Related]
8. The lightning-fast quest for COVID vaccines - and what it means for other diseases.
Ball P
Nature; 2021 Jan; 589(7840):16-18. PubMed ID: 33340018
[No Abstract] [Full Text] [Related]
9. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
[No Abstract] [Full Text] [Related]
10. Considerations in boosting COVID-19 vaccine immune responses.
Krause PR; Fleming TR; Peto R; Longini IM; Figueroa JP; Sterne JAC; Cravioto A; Rees H; Higgins JPT; Boutron I; Pan H; Gruber MF; Arora N; Kazi F; Gaspar R; Swaminathan S; Ryan MJ; Henao-Restrepo AM
Lancet; 2021 Oct; 398(10308):1377-1380. PubMed ID: 34534516
[No Abstract] [Full Text] [Related]
11. What constitutes success in the roll-out of COVID-19 vaccines?
Smith MJ
Lancet; 2021 Jul; 398(10295):115-116. PubMed ID: 34181882
[No Abstract] [Full Text] [Related]
12. Peruvian COVID-19 vaccine scandal spreads.
Chauvin L
Lancet; 2021 Feb; 397(10276):783. PubMed ID: 33640052
[No Abstract] [Full Text] [Related]
13. The long road ahead for COVID-19 vaccination in Africa.
Jerving S
Lancet; 2021 Sep; 398(10303):827-828. PubMed ID: 34481563
[No Abstract] [Full Text] [Related]
14. Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development.
Baay M; Neels P
Front Immunol; 2021; 12():658783. PubMed ID: 33777056
[No Abstract] [Full Text] [Related]
15. An African plan to control COVID-19 is urgently needed.
The Lancet
Lancet; 2020 Dec; 396(10265):1777. PubMed ID: 33278920
[No Abstract] [Full Text] [Related]
16. Will Omicron end the pandemic? Here's what experts say.
Adam D
Nature; 2022 Feb; 602(7895):20-21. PubMed ID: 35102287
[No Abstract] [Full Text] [Related]
17. Immunology Lessons from the SARS-CoV-2 Pandemic.
Yokoyama WM; Hogquist KA; O'Shea JJ
Annu Rev Immunol; 2021 Apr; 39():v-vii. PubMed ID: 33939926
[No Abstract] [Full Text] [Related]
18. COVID vaccine makers brace for a variant worse than Delta.
Waltz E
Nature; 2021 Oct; 598(7882):552-553. PubMed ID: 34671153
[No Abstract] [Full Text] [Related]
19. Could mixing COVID vaccines boost immune response?
Ledford H
Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
[No Abstract] [Full Text] [Related]
20. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2.
Book BAJ; Schmidt B; Foerster AMH
JAMA Ophthalmol; 2021 Jul; 139(7):e212471. PubMed ID: 34287612
[No Abstract] [Full Text] [Related]
[Next] [New Search]
